A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

October 19, 2016

Primary Completion Date

September 6, 2019

Study Completion Date

October 2, 2023

Conditions
Muscular Atrophy, Spinal
Interventions
DRUG

Placebo

Placebo will be administered orally (via mouth) or through a feeding tube (naso-gastric or gastrostomy tube).

DRUG

Risdiplam

Risdiplam will be administered orally (via mouth) or through a feeding tube (naso-gastric or gastrostomy tube).

Trial Locations (45)

3000

UZ Leuven Gasthuisberg, Leuven

4000

Chr de La Citadelle, Liège

9000

UZ Gent, Ghent

10000

Clinical Medical Center Zagreb; University Hospital Rebro Department of Paediatrics, Zagreb

10032

Columbia University Medical Center; The Neurological Institute of New York, New York

11000

Clinic for Neurology and Psychiatry for Children and Youth, Belgrade

16147

IRCCS Istituto Giannina Gaslini; U.O.S.D. Centro di Miologia e Patologie Neurodegenerative, Genoa

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Unità Operativa Complessa di Neurologia, Milan

20133

Fondazione IRCCS Istituto Neurologico ?Carlo Besta?; UO di Neurologia dello Sviluppo, Milan

34752

Hospital Yeditepe University Kozyatagi; Pediatry, Atasehir- Istanbul

41013

Hospital Universitario Virgen del Rocío, Seville

44093

CHU de Nantes - Hotel Dieu, Nantes

59037

Hopital Roger Salengro, Lille

69677

Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique ? L?ESCALE, Bron

75015

Hôpital Necker-Enfants Malades; Service de neuropédiatrie, Paris

75571

Hopital Armand Trousseau, Paris

79106

Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen, Freiburg im Breisgau

94304

Stanford University Medical Center, Palo Alto

100034

Peking University First Hospital, Beijing

125412

Russian Children Neuromuscular Center of Veltischev, Moscow

201102

Children's Hospital of Fudan University, Shanghai

280146

Hospital Universitario La Paz, Madrid

CEP 21941-912

Instituto de Puericultura E Pediatria Martagão Gesteira, Rio de Janeiro

T3B 6A8

Alberta Children's Hospital Division of Pediatric Neurology, Calgary

N6A 5W9

London Health Sciences Centre; Children's Hospital; Pediatrics, London

H4A 3J1

McGill University Health Centre - Glen Site, Montreal

00165

IRCCS Ospedale Pediatrico Bambino Gesù; U.O. Malattie Neuromuscolari e Neurodegenerative, Rome

00168

Policlinico Agostino Gemelli; Dipartimento di Neuropsichiatria Infantile, Rome

813-0017

Fukuoka Children's Hospital, Fukuoka

734-8551

Hiroshima University Hospital, Hiroshima

663-8501

Hyogo Medical University Hospital, Hyōgo

899-5293

Minami Kyushu National Hospital, Kagoshima

989-3126

Miyagi Children's Hospital, Miyagi

524-0022

Shiga Medical Center for Children, Shiga

420-8660

Shizuoka Children's Hospital, Shizuoka

329-0498

Jichi Medical University Hospital, Tochigi

162-0052

Center Hospital of the National Center for Global Health and Medicine, Tokyo

187-8551

National Center Of Neurology And Psychiatry Hospital, Tokyo

80-952

Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology, Gda?sk

60-355

Uniwersytecki Szpital Kliniczny w Poznaniu; Od. Kliniczny Neurologii Dzieci i M?odziezy, Późna

02-097

Klinika Neurologii I Wydzialu Lekarskiego WUM w Warszawie, Warsaw

08950

Hospital Sant Joan De Deu, Esplugues de Llobregas

08035

Hospital Universitari Vall d'Hebron; Servicio de Reumatologia, Barcelona

06100

Hacettepe University, School of Medicine; Pediatrics Department; Pediatrics Child Neurology Unit, Ankara

OX3 9DU

University of Oxford; Department of Paediatrics, Headington

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02908685 - A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants | Biotech Hunter | Biotech Hunter